Andrew G. Hinson
Director/Board Member chez BioVentrix, Inc.
Profil
Andrew G.
Hinson is currently the Director at BioVentrix, Inc. and Vice President-Regulatory & Clinical Affairs at CardioPolymers, Inc. He was previously an Independent Director at BioLife Solutions, Inc. from 2007 to 2021, Vice President-Clinical & Regulatory Affairs at LoneStar Heart, Inc. from 2004 to 2016, and Senior Manager-Medical & Scientific Affairs at Procter & Gamble Pharmaceuticals, Inc. He also served as Senior Director-Clinical Development at AnGes USA, Inc. Mr. Hinson received his undergraduate degree from the University of Cincinnati (Ohio).
Postes actifs de Andrew G. Hinson
Sociétés | Poste | Début |
---|---|---|
CardioPolymers, Inc.
CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | General Counsel | 01/11/2004 |
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA. | Director/Board Member | 21/07/2021 |
Anciens postes connus de Andrew G. Hinson
Sociétés | Poste | Fin |
---|---|---|
BIOLIFE SOLUTIONS, INC. | Director/Board Member | 20/09/2021 |
LoneStar Heart, Inc.
LoneStar Heart, Inc. Miscellaneous Commercial ServicesCommercial Services LoneStar Heart, Inc. develops cardiac restorative therapies for patients with heart failure. The firm functions in collaboration with the Texas Heart Institute, the University of Texas Southwestern Medical Center and a global network of leading clinicians. Its flagship product is Algisyl-LVR, a medical device under clinical development intended to prevent or reverse the progression of advanced heart failure in patients who have an enlarged left ventricle. The company was founded in June 2010 by James T. Willerson, Eric N. Olson and Olav B. Bergheim and is headquartered in Laguna Hills, CA. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
AnGes USA, Inc.
AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The private company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Corporate Officer/Principal | - |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
Formation de Andrew G. Hinson
University of Cincinnati (Ohio) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOLIFE SOLUTIONS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA. | Health Technology |
LoneStar Heart, Inc.
LoneStar Heart, Inc. Miscellaneous Commercial ServicesCommercial Services LoneStar Heart, Inc. develops cardiac restorative therapies for patients with heart failure. The firm functions in collaboration with the Texas Heart Institute, the University of Texas Southwestern Medical Center and a global network of leading clinicians. Its flagship product is Algisyl-LVR, a medical device under clinical development intended to prevent or reverse the progression of advanced heart failure in patients who have an enlarged left ventricle. The company was founded in June 2010 by James T. Willerson, Eric N. Olson and Olav B. Bergheim and is headquartered in Laguna Hills, CA. | Commercial Services |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Health Technology |
CardioPolymers, Inc.
CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Health Technology |
AnGes USA, Inc.
AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The private company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Health Technology |